*In clinical trials studying Wegovy® (2.4 mg), the average weight loss was 15% and 20%, respectively, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone). Results may vary. Compounded medications are not FDA-approved and are made by a licensed pharmacy based on a provider’s prescription.

AOD-9604 Metabolic Protocol

Supports fat metabolism through targeted lipolysis — without binding the GH receptor or elevating IGF-1.

Starting at $XXX/month

AOD-9604 is a synthetic fragment of human growth hormone — specifically the 15-amino acid C-terminal sequence responsible for GH's fat-burning activity. It holds FDA GRAS designation and completed Phase IIb human trials, making it the most clinically tested body composition peptide on Shed's list.

Join the waitlist →

FAQ

Is AOD-9604 FDA approved?

It holds FDA GRAS (Generally Recognized as Safe) designation — the only peptide on Shed's list with this FDA recognition. It is not FDA-approved as a drug.

FAQ

Do I need labs first?

FAQ

How long is a protocol?

FAQ

How is it delivered?

Physician Supervised • Lab-Monitored • FDA-Registered Pharmacy • Evidence-Reviewed •

What is AOD-9604?

AOD-9604 (Anti-Obesity Drug 9604) is a synthetic 15-amino acid peptide corresponding to residues 177–191 of human growth hormone — the specific region of the GH molecule responsible for its lipolytic (fat-burning) activity. Developed by Professor Frank Ng and colleagues at Monash University in the late 1990s, its design objective was precise: isolate GH's fat metabolism benefits while eliminating its growth-promoting and metabolic side effects.

The result is a compound that activates beta-3 adrenergic lipolysis without binding to the GH receptor — meaning no IGF-1 elevation, no insulin resistance, and no tissue growth effects. Phase IIb human trials in obese adults documented statistically significant fat reduction versus placebo, and FDA granted GRAS status based on the safety profile.

AOD-9604 stands alone on Shed's list for having completed rigorous human trials and earned formal FDA safety recognition.

Join the waitlist →

Benefit deep dive

Heading

Daily support to help maintain cellular energy.

No items found.

Join the waitlist →

See if you qualify →

How AOD-9604 Works

Designed to support circulation and the body’s natural recovery pathways

Beta-3 Adrenergic Activation

AOD-9604 activates beta-3 adrenergic receptors on adipocytes (fat cells), triggering the lipolytic cascade that releases fatty acids from stored fat into circulation for use as fuel.

GH Receptor Independence

By targeting only the C-terminal fragment responsible for lipolysis — not the N-terminal domain that binds the GH receptor — AOD-9604 produces fat metabolism effects without the downstream IGF-1 elevation, insulin resistance, or tissue growth of full GH.

Lipogenesis Block

Simultaneously, AOD-9604 inhibits fat cell differentiation and new lipid synthesis, reducing the rate at which carbohydrates are converted to body fat — a complementary mechanism to its direct lipolytic activity.

Your AOD-9604 plan, made simple

3-minute medical intake. Provider-led. 100% online.

Step 1

Complete your online consultation

You fill out a brief medical intake about your goals, symptoms, and health history. This helps your provider determine if AOD-9604 is appropriate for you.

Step 2

Provider review & personalized plan

A licensed clinician reviews your case and creates a tailored BPC-157 plan based on your needs.

Step 3

Medication compounded & shipped to you

If approved, your AOD-9604 is prepared by a U.S.-based compounding pharmacy and delivered directly to your door.

Step 4

Ongoing support inside your Shed portal

Ask questions, request adjustments, and get support anytime from your care team.

Join the waitlist →

Shed FAQs